Skip to main content
HeartCited

NMN (Nicotinamide Mononucleotide) for Heart Failure

D

Preclinical data shows NAD+ restoration may support cardiac function in animal heart failure models. No human heart failure trials yet. Mechanism through SIRT1 activation and mitochondrial biogenesis.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnmn\u0026condition\u003Dheart\u002Dfailure'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            D

        

        

            
The Bottom Line

            
            
Preclinical data shows NAD+ restoration may support cardiac function in animal heart failure models. No human heart failure trials yet. Mechanism through SIRT1 activation and mitochondrial biogenesis.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
0

        
Studies

    

    

        
--

        
Participants

    

    

        
            
            ↑
            
        
        
Positive

    

    

        D

        
Grade

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
Commonly Used Dosages

                

                    
                    

                        
general:

                        
250-500 mg/day

                    

                    
                    

                        
antiagingprotocols:

                        
500-1,000 mg/day

                    

                    
                

                
                

                    Upper limit: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e
                

                
            

            

            

            
            

                Best taken: Morning on empty stomach or with light meal; sublingual for enhanced bioavailability
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
Reported Side Effects

                    
    
                        
                        
  • 
                            ⚠
                            Generally well-tolerated
                        
    • 
                        
                        
  • 
                            ⚠
                            Mild gastrointestinal discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            Flushing (rare)
                        
    • 
                        
                        
  • 
                            ⚠
                            Headache (rare)
                        
    • 
                        
                    

                

                

                
                

                    
Known Interactions

                    
    
                        
                        
  • 
                            ●
                            May interact with NAD+-dependent medications
                        
    • 
                        
                        
  • 
                            ●
                            Theoretical interaction with diabetes medications (may affect glucose metabolism)
                        
    • 
                        
                    

                

                

                
                

                    

                        Tolerable upper intake: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e
                    

                

                
            

            

                Always consult your healthcare provider before starting any supplement.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does NMN (Nicotinamide Mononucleotide) help with Heart Failure?
            
        
        

            Based on 0 studies with 0 participants, there is preliminary evidence that needs more research that NMN (Nicotinamide Mononucleotide) may support Heart Failure management. Our evidence grade is D (Very Early Research).
        

    

    
    

        
            How much NMN (Nicotinamide Mononucleotide) should I take for Heart Failure?
            
        
        

            Studies have used various dosages. A commonly studied range is 250-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of NMN (Nicotinamide Mononucleotide)?
            
        
        

            Reported side effects may include Generally well-tolerated, Mild gastrointestinal discomfort, Flushing (rare), Headache (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for NMN (Nicotinamide Mononucleotide) and Heart Failure?
            
        
        

            We rate the evidence as Grade D (Very Early Research). This rating is based on 0 peer-reviewed studies with 0 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
                

                    
NMN (Nicotinamide Mononucleotide) for other conditions

                    

                        
                        
                            Arterial Stiffness
                            C

                        
                        
                    

                

                
            

        

        

    


    
    












    

        FDA Disclaimer:
        These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.